Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: techniques to optimize potential (TOP)
Total 0 results
Nothing found
Sponsors and Collaborators
Brigham and Womens' Hospital, Center for Surgery and Public Health
Australian Childhood Foundation
Zhijun Sun
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
Carlos III Health Institute
Sonogenix
Epicentre, Paris, France.
Kettering Foundation
Paul W. Read, MD
NATURAmedicatrix Sàrl
Laboratoires Iprad-Vegebom
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
Remedy Institute
Prader-Willi Syndrome Association of Australia
Sociedad Española de Arteriosclerosis
Health Holding Company, Hail Health Cluster, Saudi Arabia
wenbinlu
Resurge Therapeutics Inc.
View Full List
Medical Conditions
Adherence to In-Office Glaucoma Evaluation Appointment
Ankle Trauma
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Stage III Childhood Anaplastic Large Cell Lymphoma
Cell Senescence
Pregnancy; Accident
Psychoactive Substance Use
Escape Room Games and Role Playing Gamification
Refractory B-Lineage Lymphoma
Lymphoblastic Lymphoma
Apneic; Oxygenation
Mycobacterium Avium Complex Infections
Marginal Zone B-cell Lymphoma
Intervention Studies
Stroke Recrudescence
Stage IIIB Esophageal Adenocarcinoma
Hernia,Ventral
Spinocerebellar Ataxia Genotype Type 3
Neurobehavioral Manifestation
Malignant Tumor of Extrahepatic Bile Duct
View Full List
Drug Interventions
Lansoprazole 15mg QD
300 mg of caffeine citrate infusion
ART-123
Colecalciferol D3 (Vigantol Oil)
Triple therapy
FRSW107
Fenofibric acid 135mg
Optiva artificial tear by Allergan
Fostamatinib
LINjeta U-100 Insulin
Irinotecan
Gadoteridol (ProHance)
Oral Aztreonam
Omeprazole 40 mg
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
Epalrestat
Everolimus
SBI-087
Low molecular weight Heparin as standard of care treatment
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
View Full List
CROs by country
Contract Research Organizations in Cameroon
Contract Research Organizations in Canada
Contract Research Organizations in Chile
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Ethiopia
Contract Research Organizations in Hong Kong
Contract Research Organizations in Italy
Contract Research Organizations in Liberia
Contract Research Organizations in Madagascar
Contract Research Organizations in Malawi
Contract Research Organizations in Mauritius
Contract Research Organizations in Venezuela
CRO list by country
CROs in Tanzania
SGS
Dokumeds
ACROSS Global
All CROs in Tanzania
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe